Fibroadenoma of the breast is a common cause of a benign breast lump in pre
menopausal women.
The consensus view is that women with fibroadenomas are not at significant
increased risk of developing breast cancer.
Diagnosis is based on the combination of clinical examination, imaging and
non-surgical tissue biopsy (the triple test).
A clinical diagnosis of fibroadenoma alone is unreliable and does not exclu
de malignancy even in younger women.
The choice of imaging is mammography, combined with ultrasound in older wom
en, and ultrasound alone in younger women.
Tissue biopsy, by either fine-needle aspiration or core biopsy, is the most
accurate means of establishing the diagnosis.
Traditionally, symptomatic fibroadenomas were treated by surgical excision,
and this option should always be offered.
There is increasing evidence that a conservative approach is safe and accep
table, provided the result of an adequate triple test is both negative for
cancer and consistent with a fibroadenoma.
Patients who choose conservative management need to be informed of the limi
tation of the tests, and must be assessed promptly if there is symptomatic
or clinical change.